Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lutz, FL
NPI
1336102383
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
18938 N Dale Mabry Hwy Ste 101
Lutz, FL, 33548
Phone (813) 573-0064
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
302 services
Medicare patients, 2024
139
Average age 72
Drug cost, 2024
$1.3M
2,187 prescriptions
Company payments, 2025
$271
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Judy A Barzey was code 99214 (office e&m - established), 237 times for 125 patients. In total Judy A Barzey billed 302 services in 7 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 237 | 125 | $83.83 | $20K |
| 95251 Test - Miscellaneous | Office | 23 | 20 | $26.44 | $608 |
| 99213 Office E&M - Established | Office | 22 | 19 | $50.93 | $1,120 |
By year: 2022 $28K for 331 services; 2023 $30K for 344 services; 2024 $23K for 302 services.
Medicare prescription drug claims, 2024
In 2024, the drug Judy A Barzey prescribed most often to Medicare patients was Levothyroxine Sodium, with 236 prescriptions and refills. In total Judy A Barzey wrote 2,187 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 236 | 635 | 80 | $2,686 |
| Ozempic Semaglutide | 115 | 190 | 25 | $182K |
| Mounjaro Tirzepatide | 94 | 123 | 20 | $130K |
| Metformin Hcl Generic | 93 | 252 | 35 | $702 |
| Metformin Hcl Er Metformin Hcl | 93 | 269 | 38 | $820 |
| Farxiga Dapagliflozin Propanediol | 84 | 157 | 28 | $86K |
| Jardiance Empagliflozin | 81 | 155 | 20 | $92K |
| Rybelsus Semaglutide | 59 | 91 | 15 | $86K |
| Trulicity Dulaglutide | 58 | 72 | 14 | $71K |
| Tresiba Flextouch U-100 Insulin Degludec | 58 | 86 | 21 | $45K |
| Prolia Denosumab | 55 | 330 | 37 | $96K |
| Humalog Insulin Lispro | 53 | 95 | 12 | $16K |
| Pioglitazone Hcl Generic | 51 | 116 | 16 | $547 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 51 | 123 | 16 | $8,693 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 50 | 76 | 12 | $42K |
Brand drugs: 1,343 claims; generic drugs: 706 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Judy A Barzey $271 ($271 in general payments such as food, travel and fees) from 7 companies. The largest payer was Lilly USA, LLC with $141.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.